Why MBRX? Moleculin Biotech, Inc. Analysis, Price & AI Insights | Whystock
MBRX
$2.51-0.05 (-1.95%)
Market ClosedLast close May 1
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.